The Role of Obsessive-Compulsive Factors in the Treatment of Binge-Eating Disorders: A Post-Hoc Analysis of a Double-Blind, Placebo-Controlled Trial of Dasotraline

被引：0
|
作者：
Loebel, Antony [1 ]
Goldman, Robert [1 ]
Citrome, Leslie [1 ]
Siu, Cynthia [1 ]
Tsai, Joyce [1 ]
Kent, Justine [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Binge Eating Disorder; Obsessive Compulsive Disorder; Dasotraline;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M68
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [21] A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder
    Shapira, NA
    Ward, HE
    Mandoki, M
    Murphy, TK
    Yang, MC
    Blier, P
    Goodman, WK
    BIOLOGICAL PSYCHIATRY, 2004, 55 (05) : 553 - 555
  • [22] A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder
    Soltani, Farhad
    Sayyah, Mehdi
    Feizy, Fariba
    Malayeri, Alireza
    Siahpoosh, Amir
    Motlagh, Ismail
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (06) : 509 - 513
  • [23] Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study
    Hollander, E
    Rossi, NB
    Sood, E
    Pallanti, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (04): : 397 - 401
  • [24] Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients
    Kamijima, K
    Murasaki, M
    Asai, M
    Higuchi, T
    Nakajima, T
    Taga, C
    Matsunaga, H
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (04) : 427 - 433
  • [25] A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response
    T. Pearlstein
    E. Spurell
    L. A. Hohlstein
    V. Gurney
    J. Read
    C. Fuchs
    M. B. Keller
    Archives of Women's Mental Health, 2003, 6 (2) : 147 - 151
  • [26] Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
    Askari, Neda
    Moin, Mandieh
    Sanati, Mohammad
    Tajdini, Masih
    Hosseini, Seyed-Mohammad-Reza
    Modabbernia, Amirhossein
    Najand, Babak
    Salimi, Samrand
    Tabrizi, Mina
    Ashrafi, Mandana
    Hajiaghaee, Reza
    Akhondzadehl, Shahin
    CNS DRUGS, 2012, 26 (10) : 883 - 892
  • [27] Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial
    Shalbafan, M.
    Mohammadinejad, P.
    Shariat, S. -V.
    Alavi, K.
    Zeinoddini, A.
    Salehi, M.
    Askari, N.
    Akhondzadeh, S.
    PHARMACOPSYCHIATRY, 2015, 48 (4-5) : 136 - 140
  • [28] Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive DisorderA Randomized, Double-Blind, Placebo-Controlled Trial
    Neda Askari
    Mahdieh Moin
    Mohammad Sanati
    Masih Tajdini
    Seyed-Mohammad-Reza Hosseini
    Amirhossein Modabbernia
    Babak Najand
    Samrand Salimi
    Mina Tabrizi
    Mandana Ashrafi
    Reza Hajiaghaee
    Shahin Akhondzadeh
    CNS Drugs, 2012, 26 : 883 - 892
  • [29] N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
    Afshar, Hamid
    Roohafza, Hamidreza
    Mohammad-Beigi, Hamid
    Haghighi, Mohammad
    Jahangard, Leila
    Shokouh, Pedram
    Sadeghi, Masoumeh
    Hafezian, Hasan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (06) : 797 - 803
  • [30] Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder
    Claudino, Angelica M.
    de Oliveira, Irismar R.
    Appolinario, Jose Carlos
    Cordas, Taki A.
    Duchesne, Monica
    Sichieri, Rosely
    Bacaltchuk, Josue
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (09) : 1324 - 1332
12345